BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stefan N, Häring HU. The metabolically benign and malignant fatty liver. Diabetes 2011;60:2011-7. [PMID: 21788578 DOI: 10.2337/db11-0231] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Xue L, Wu K, Qiu H, Huang B, Chen R, Xie W, Jiang Q. Polydatin exhibits the hepatoprotective effects through PPAR-α/-β signaling pathway in Streptozocin-induced diabetic mice. Journal of Functional Foods 2017;36:341-7. [DOI: 10.1016/j.jff.2017.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Chiloiro M, Caruso MG, Cisternino AM, Inguaggiato R, Reddavide R, Bonfiglio C, Guerra V, Notarnicola M, De Michele G, Correale M, Noviello MR, Misciagna G. Ultrasound evaluation and correlates of fatty liver disease: a population study in a Mediterranean area. Metab Syndr Relat Disord 2013;11:349-58. [PMID: 23758075 DOI: 10.1089/met.2012.0169] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
3 Schutte S, Esser D, Hoevenaars FPM, Hooiveld GJEJ, Priebe MG, Vonk RJ, Wopereis S, Afman LA. A 12-wk whole-grain wheat intervention protects against hepatic fat: the Graandioos study, a randomized trial in overweight subjects. The American Journal of Clinical Nutrition 2018;108:1264-74. [DOI: 10.1093/ajcn/nqy204] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
4 Stefan N, Häring H. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 2013;19:394-5. [DOI: 10.1038/nm.3116] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 12.1] [Reference Citation Analysis]
5 Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol 2016;12:721-37. [PMID: 27748389 DOI: 10.1038/nrneph.2016.145] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 18.8] [Reference Citation Analysis]
6 Müller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev 2012;13 Suppl 2:6-13. [PMID: 23107255 DOI: 10.1111/j.1467-789X.2012.01033.x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 69] [Article Influence: 18.2] [Reference Citation Analysis]
7 Lehmann R. Diabetes Subphenotypes and Metabolomics: The Key to Discovering Laboratory Markers for Personalized Medicine? Clinical Chemistry 2013;59:1294-6. [DOI: 10.1373/clinchem.2013.207993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Gruben N, Shiri-Sverdlov R, Koonen DP, Hofker MH. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta 2014;1842:2329-43. [PMID: 25128743 DOI: 10.1016/j.bbadis.2014.08.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
9 Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015;4:101-108. [PMID: 26005676 DOI: 10.3978/j.issn.2304-3881.2015.01.03] [Cited by in F6Publishing: 53] [Reference Citation Analysis]
10 Ungerleider NA, Bonomi LM, Brown ML, Schneyer AL. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice. Endocrinology 2013;154:2025-33. [PMID: 23533219 DOI: 10.1210/en.2012-1844] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
11 Du X, Cai C, Yao J, Zhou Y, Yu H, Shen W. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. Biochem Biophys Res Commun 2017;483:409-17. [PMID: 28027934 DOI: 10.1016/j.bbrc.2016.12.129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
12 Vilà L, Elias I, Roca C, Ribera A, Ferré T, Casellas A, Lage R, Franckhauser S, Bosch F. AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. Mol Ther Methods Clin Dev 2014;1:14039. [PMID: 26015978 DOI: 10.1038/mtm.2014.39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
13 Li Y, Sun X, Yu Y. Serum fetuin-A levels related with microalbuminuria in diet-induced obese rats. Biomed Res Int 2013;2013:795103. [PMID: 23710462 DOI: 10.1155/2013/795103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
14 Renne U, Langhammer M, Brenmoehl J, Walz C, Zeissler A, Tuchscherer A, Piechotta M, Wiesner RJ, Bielohuby M, Hoeflich A. Lifelong obesity in a polygenic mouse model prevents age- and diet-induced glucose intolerance- obesity is no road to late-onset diabetes in mice. PLoS One 2013;8:e79788. [PMID: 24236159 DOI: 10.1371/journal.pone.0079788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
15 Fenske W, Athanasiou T, Harling L, Drechsler C, Darzi A, Ashrafian H. Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Rev Nephrol 2013;9:539-51. [PMID: 23917797 DOI: 10.1038/nrneph.2013.145] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
16 Rashidmayvan M, Mohammadshahi M, Seyedian SS, Haghighizadeh MH. The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. J Diabetes Metab Disord 2019;18:453-9. [PMID: 31890671 DOI: 10.1007/s40200-019-00439-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
17 Santoro N, Feldstein AE, Enoksson E, Pierpont B, Kursawe R, Kim G, Caprio S. The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants. Diabetes Care 2013;36:1353-60. [PMID: 23275357 DOI: 10.2337/dc12-1791] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
18 Xie X, Yan D, Li H, Zhu Q, Li J, Fang YP, Cheung CW, Irwin MG, Xia Z, Lian Q. Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats. J Diabetes Res 2018;2018:6254340. [PMID: 30186875 DOI: 10.1155/2018/6254340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Perrin-Cocon L, Aublin-Gex A, Diaz O, Ramière C, Peri F, André P, Lotteau V. Toll-like Receptor 4-Induced Glycolytic Burst in Human Monocyte-Derived Dendritic Cells Results from p38-Dependent Stabilization of HIF-1α and Increased Hexokinase II Expression. J Immunol 2018;201:1510-21. [PMID: 30037846 DOI: 10.4049/jimmunol.1701522] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
20 Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59:713-723. [PMID: 23929732 DOI: 10.1002/hep.26672] [Cited by in Crossref: 382] [Cited by in F6Publishing: 355] [Article Influence: 47.8] [Reference Citation Analysis]
21 Stefan N, Fritsche A, Schick F, Häring HU. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016;4:789-98. [PMID: 27185609 DOI: 10.1016/S2213-8587(16)00082-6] [Cited by in Crossref: 103] [Cited by in F6Publishing: 35] [Article Influence: 17.2] [Reference Citation Analysis]
22 Wei J, Zhen YZ, Cui J, He FL, Shen T, Hu G, Ren XH, Lin YJ. Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver disease. Arch Pharm Res. 2016;39:960-969. [PMID: 27277164 DOI: 10.1007/s12272-016-0770-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
23 Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Curr Diab Rep. 2015;15:607. [PMID: 25894944 DOI: 10.1007/s11892-015-0607-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 8.7] [Reference Citation Analysis]
24 Cazzo E, Jimenez LS, Gallo FDF, Pareja JC, Chaim EA. Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study. Sao Paulo Med J 2016;134:79-83. [DOI: 10.1590/1516-3180.2015.01652409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
25 Højland Ipsen D, Tveden-Nyborg P, Lykkesfeldt J. Normal weight dyslipidemia: Is it all about the liver? Obesity (Silver Spring) 2016;24:556-67. [PMID: 26868960 DOI: 10.1002/oby.21443] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
26 Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev. 2019;40:1367-1393. [PMID: 31098621 DOI: 10.1210/er.2019-00034] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 33.0] [Reference Citation Analysis]
27 Stienstra R, Stefan N. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia 2013;56:2343-6. [DOI: 10.1007/s00125-013-3040-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
28 Wierzbicki AS, Oben J. Nonalcoholic fatty liver disease and lipids. Curr Opin Lipidol. 2012;23:345-352. [PMID: 22617751 DOI: 10.1097/MOL.0b013e3283541cfc] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
29 Jacobs S, Jäger S, Jansen E, Peter A, Stefan N, Boeing H, Schulze MB, Kröger J. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study. PLoS One 2015;10:e0127368. [PMID: 25984792 DOI: 10.1371/journal.pone.0127368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
30 Stefan N, Staiger H, Wagner R, Machann J, Schick F, Häring HU, Fritsche A. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 2015;58:2877-84. [PMID: 26404062 DOI: 10.1007/s00125-015-3760-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
31 Basu A, Basu P, Lyons TJ. Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals. In: Patel VB, Preedy VR, editors. Biomarkers in Liver Disease. Dordrecht: Springer Netherlands; 2017. pp. 957-75. [DOI: 10.1007/978-94-007-7675-3_35] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Häring HU. Novel phenotypes of prediabetes? Diabetologia 2016;59:1806-18. [PMID: 27344314 DOI: 10.1007/s00125-016-4015-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
33 Rajas F, Labrune P, Mithieux G. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders. Diabetes & Metabolism 2013;39:377-87. [DOI: 10.1016/j.diabet.2013.03.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
34 Kim G, Giannini C, Pierpont B, Feldstein AE, Santoro N, Kursawe R, Shaw M, Duran E, Goldberg R, Dziura J. Longitudinal effects of MRI-measured hepatic steatosis on biomarkers of glucose homeostasis and hepatic apoptosis in obese youth. Diabetes Care. 2013;36:130-136. [PMID: 22933439 DOI: 10.2337/dc12-0277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
35 Barrera J, Chambliss KL, Ahmed M, Tanigaki K, Thompson B, McDonald JG, Mineo C, Shaul PW. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract. Am J Physiol Endocrinol Metab 2014;307:E345-54. [PMID: 24939737 DOI: 10.1152/ajpendo.00653.2013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
36 Taskinen MR, Borén J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis 2015;239:483-95. [PMID: 25706066 DOI: 10.1016/j.atherosclerosis.2015.01.039] [Cited by in Crossref: 198] [Cited by in F6Publishing: 172] [Article Influence: 28.3] [Reference Citation Analysis]
37 Mackey RH, Mctigue KM, Kuller LH. The Obesity Epidemic and Women’s Health. Women and Health. Elsevier; 2013. pp. 855-71. [DOI: 10.1016/b978-0-12-384978-6.00056-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Randrianarisoa E, Lehn-Stefan A, Hieronimus A, Rietig R, Fritsche A, Machann J, Balletshofer B, Häring HU, Stefan N, Rittig K. Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus. J Atheroscler Thromb 2019;26:821-34. [PMID: 30787215 DOI: 10.5551/jat.47274] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
39 Tao R, Wang C, Stöhr O, Qiu W, Hu Y, Miao J, Dong XC, Leng S, Stefater M, Stylopoulos N, Lin L, Copps KD, White MF. Inactivating hepatic follistatin alleviates hyperglycemia. Nat Med 2018;24:1058-69. [PMID: 29867232 DOI: 10.1038/s41591-018-0048-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
40 Bartolini D, Torquato P, Barola C, Russo A, Rychlicki C, Giusepponi D, Bellezza G, Sidoni A, Galarini R, Svegliati-Baroni G, Galli F. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E). J Nutr Biochem 2017;47:120-31. [PMID: 28628909 DOI: 10.1016/j.jnutbio.2017.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
41 Randrianarisoa E, Stefan N, Fritsche A, Reis-Damaschk N, Hieronimus A, Balletshofer B, Machann J, Siegel-Axel D, Häring HU, Rittig K. Periaortic Adipose Tissue Compared With Peribrachial Adipose Tissue Mass as Markers and Possible Modulators of Cardiometabolic Risk. Angiology 2018;69:854-60. [PMID: 29444588 DOI: 10.1177/0003319718755581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
42 Cheng S, Ge J, Zhao C, Le S, Yang Y, Ke D, Wu N, Tan X, Zhang X, Du X, Sun J, Wang R, Shi Y, Borra RJH, Parkkola R, Wiklund P, Lu D. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial. Sci Rep 2017;7:15952. [PMID: 29162875 DOI: 10.1038/s41598-017-16159-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
43 Challal S, Minichiello E, Boissier MC, Semerano L. Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes. Joint Bone Spine 2016;83:127-33. [PMID: 26184539 DOI: 10.1016/j.jbspin.2015.04.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
44 Conceicao RDO, Oni E, Laurinavicius AG, D. Santos R. Non Alcoholic Fatty Liver: Should We Care? Curr Cardiovasc Risk Rep 2014;8. [DOI: 10.1007/s12170-014-0384-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Ratziu V, Marchesini G. When the journey from obesity to cirrhosis takes an early start. Journal of Hepatology 2016;65:249-51. [DOI: 10.1016/j.jhep.2016.05.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
46 Stefan N, Artunc F, Heyne N, Machann J, Schleicher ED, Häring HU. Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. Nephrol Dial Transplant 2016;31:726-30. [PMID: 24753460 DOI: 10.1093/ndt/gfu081] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
47 Fritsche L, Sarief M, Wagner R, Stefan N, Lehmann R, Häring HU, Grallert H, Fritsche A, Lechner A. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits. Diabetes Res Clin Pract 2018;146:251-7. [PMID: 30419301 DOI: 10.1016/j.diabres.2018.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
48 Lim S, Oh TJ, Koh KK. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Int J Cardiol 2015;201:408-14. [PMID: 26310987 DOI: 10.1016/j.ijcard.2015.08.107] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
49 Yamasaki N, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Kaga H, Suzuki R, Sugimoto D, Kadowaki S, Sato M, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Satoh H, Kawamori R, Watada H. Both higher fitness level and higher current physical activity level may be required for intramyocellular lipid accumulation in non-athlete men. Sci Rep 2020;10:4102. [PMID: 32139784 DOI: 10.1038/s41598-020-61080-5] [Reference Citation Analysis]
50 Pala L, Barbaro V, Dicembrini I, Rotella CM. The therapy of insulin resistance in other diseases besides type 2 diabetes. Eat Weight Disord 2014;19:275-83. [PMID: 25069836 DOI: 10.1007/s40519-014-0139-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
51 Bonsembiante L, Targher G, Maffeis C. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? Eur J Clin Nutr 2021. [PMID: 34006994 DOI: 10.1038/s41430-021-00928-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Cheng Z, White MF. kNOXing on the door of selective insulin resistance. Arterioscler Thromb Vasc Biol 2012;32:1063-5. [PMID: 22517360 DOI: 10.1161/ATVBAHA.112.246868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Zeng F, Luo J, Han H, Xie W, Wang L, Han R, Chen H, Cai Y, Huang H, Xia Z. Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2. Int J Immunopathol Pharmacol 2021;35:20587384211031417. [PMID: 34240649 DOI: 10.1177/20587384211031417] [Reference Citation Analysis]
54 Gutierrez AD, Balasubramanyam A. Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine. 2012;41:1-10. [PMID: 22134974 DOI: 10.1007/s12020-011-9565-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
55 Abu-Toamih Atamni HJ, Botzman M, Mott R, Gat-Viks I, Iraqi FA. Mapping novel genetic loci associated with female liver weight variations using Collaborative Cross mice. Animal Model Exp Med 2018;1:212-20. [PMID: 30891567 DOI: 10.1002/ame2.12036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
56 Shigiyama F, Kumashiro N, Furukawa Y, Funayama T, Takeno K, Wakui N, Ikehara T, Nagai H, Taka H, Fujimura T, Uchino H, Tamura Y, Watada H, Nemoto T, Shiraga N, Sumino Y, Hirose T. Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. Hepatol Commun 2017;1:634-47. [PMID: 29404483 DOI: 10.1002/hep4.1077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
57 Cheng S, Wiklund P, Autio R, Borra R, Ojanen X, Xu L, Törmäkangas T, Alen M. Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. PLoS One 2015;10:e0138889. [PMID: 26439744 DOI: 10.1371/journal.pone.0138889] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
58 Irie K, Ekuni D, Tomofuji T, Morita M. Periodontitis and Liver Diseases. In: Ekuni D, Battino M, Tomofuji T, Putnins EE, editors. Studies on Periodontal Disease. New York: Springer; 2014. pp. 197-209. [DOI: 10.1007/978-1-4614-9557-4_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
59 Lubura M, Hesse D, Kraemer M, Hallahan N, Schupp M, von Löffelholz C, Kriebel J, Rudovich N, Pfeiffer A, John C, Scheja L, Heeren J, Koliaki C, Roden M, Schürmann A. Diabetes prevalence in NZO females depends on estrogen action on liver fat content. Am J Physiol Endocrinol Metab 2015;309:E968-80. [PMID: 26487005 DOI: 10.1152/ajpendo.00338.2015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
60 Huang LL, Guo DH, Xu HY, Tang ST, Wang XX, Jin YP, Wang P. Association of liver enzymes levels with fasting plasma glucose levels in Southern China: a cross-sectional study. BMJ Open 2019;9:e025524. [PMID: 31630095 DOI: 10.1136/bmjopen-2018-025524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Forcisi S, Moritz F, Lucio M, Lehmann R, Stefan N, Schmitt-Kopplin P. Solutions for low and high accuracy mass spectrometric data matching: a data-driven annotation strategy in nontargeted metabolomics. Anal Chem 2015;87:8917-24. [PMID: 26197019 DOI: 10.1021/acs.analchem.5b02049] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
62 Stefan N, Ramsauer M, Jordan P, Nowotny B, Kantartzis K, Machann J, Hwang JH, Nowotny P, Kahl S, Harreiter J, Hornemann S, Sanyal AJ, Stewart PM, Pfeiffer AF, Kautzky-Willer A, Roden M, Häring HU, Fürst-Recktenwald S. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2014;2:406-16. [PMID: 24795254 DOI: 10.1016/S2213-8587(13)70170-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
63 Guo VY, Cao B, Cai C, Cheng KK, Cheung BMY. Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol 2018;55:87-98. [PMID: 29127490 DOI: 10.1007/s00592-017-1068-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
64 Heianza Y, Arase Y, Tsuji H, Fujihara K, Saito K, Hsieh SD, Tanaka S, Kodama S, Hara S, Sone H. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J Clin Endocrinol Metab. 2014;99:2952-2960. [PMID: 24823457 DOI: 10.1210/jc.2013-4427] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
65 Cohen RV. Comment on: Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass lead to equal changes in body composition and energy metabolism 17 months postoperatively: a prospective randomized trial. Surg Obes Relat Dis 2016;12:570-1. [PMID: 26686310 DOI: 10.1016/j.soard.2015.09.002] [Reference Citation Analysis]
66 Syed AA, Reza MI, Shafiq M, Kumariya S, Singh P, Husain A, Hanif K, Gayen JR. Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis. Life Sci 2020;257:118118. [PMID: 32702445 DOI: 10.1016/j.lfs.2020.118118] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
67 Wei S, Liu S, Su X, Wang W, Li F, Deng J, Lyu Y, Geng B, Xu G. Spontaneous development of hepatosteatosis in perilipin-1 null mice with adipose tissue dysfunction. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:212-8. [PMID: 29191637 DOI: 10.1016/j.bbalip.2017.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
68 Buckley AJ, Thomas EL, Lessan N, Trovato FM, Trovato GM, Taylor-robinson SD. Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. Diabetes Research and Clinical Practice 2018;144:144-52. [DOI: 10.1016/j.diabres.2018.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
69 Silbernagel G, Lütjohann D, Machann J, Meichsner S, Kantartzis K, Schick F, Häring HU, Stefan N, Fritsche A. Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose/glucose intake in healthy humans. Exp Diabetes Res 2012;2012:361863. [PMID: 22203835 DOI: 10.1155/2012/361863] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
70 Stefan N, Sun Q, Fritsche A, Machann J, Schick F, Gerst F, Jeppesen C, Joost HG, Hu FB, Boeing H, Ullrich S, Häring HU, Schulze MB. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One 2014;9:e92238. [PMID: 24643166 DOI: 10.1371/journal.pone.0092238] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
71 Jadeja RN, Devkar RV. Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 615-23. [DOI: 10.1016/b978-0-12-398456-2.00047-5] [Cited by in Crossref: 12] [Article Influence: 1.5] [Reference Citation Analysis]
72 Khammas ASA, Hassan HA, Salih SQM, Kadir H, Ibrahim RM, Nasir NNM, Mahmud R. Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. Porto Biomed J 2019;4:e31. [PMID: 31595260 DOI: 10.1016/j.pbj.0000000000000031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
73 Saremi L, Lotfipanah S, Mohammadi M, Hosseinzadeh H, Fathi-kazerooni M, Johari B, Saltanatpour Z. The Pro12Ala polymorphism in the PPAR­γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus. Cell Mol Biol Lett 2019;24. [DOI: 10.1186/s11658-019-0138-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
74 Caravatto PP, Petry T, Cohen R. Changing Guidelines for Metabolic Surgery: Now It’s the Time! Curr Atheroscler Rep 2016;18. [DOI: 10.1007/s11883-016-0600-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
75 Oosterveer MH, Schoonjans K. Hepatic glucose sensing and integrative pathways in the liver. Cell Mol Life Sci 2014;71:1453-67. [DOI: 10.1007/s00018-013-1505-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
76 Kim Y, Lee H, Kim SY, Lim Y. Effects of Lespedeza Bicolor Extract on Regulation of AMPK Associated Hepatic Lipid Metabolism in Type 2 Diabetic Mice. Antioxidants (Basel) 2019;8:E599. [PMID: 31795363 DOI: 10.3390/antiox8120599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
77 Minkina O, Cheverud JM, Fawcett G, Semenkovich CF, Kenney-Hunt JP. Quantitative trait loci affecting liver fat content in mice. G3 (Bethesda) 2012;2:1019-25. [PMID: 22973538 DOI: 10.1534/g3.112.003343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
78 Guo CA, Kogan S, Amano SU, Wang M, Dagdeviren S, Friedline RH, Aouadi M, Kim JK, Czech MP. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance. Am J Physiol Endocrinol Metab 2013;304:E951-63. [PMID: 23482447 DOI: 10.1152/ajpendo.00514.2012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
79 Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 2013;1:152-62. [PMID: 24622321 DOI: 10.1016/S2213-8587(13)70062-7] [Cited by in Crossref: 359] [Cited by in F6Publishing: 188] [Article Influence: 39.9] [Reference Citation Analysis]
80 Cardellini M, Menghini R, Luzi A, Davato F, Cardolini I, D'Alfonso R, Gentileschi P, Rizza S, Marini MA, Porzio O, Lauro D, Sbraccia P, Lauro R, Federici M. Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness. Diabetes 2011;60:3265-70. [PMID: 21984580 DOI: 10.2337/db11-0162] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
81 Jung TW, Yoo HJ, Choi KM. Implication of hepatokines in metabolic disorders and cardiovascular diseases. BBA Clin 2016;5:108-13. [PMID: 27051596 DOI: 10.1016/j.bbacli.2016.03.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
82 Linder K, Springer F, Machann J, Schick F, Fritsche A, Häring H, Blumenstock G, Ranke MB, Stefan N, Binder G, Ehehalt S. Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults: Insulin Resistance in Adolescents and Adults. Obesity 2014;22:1325-31. [DOI: 10.1002/oby.20685] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
83 Cohen R, Caravatto PP, Petry T. Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of & lt; 35 kg/m(2): A Surgeon’s Perspective. Obes Surg. 2013;23:809-818. [PMID: 23564465 DOI: 10.1007/s11695-013-0930-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
84 Soares AF, Paz-montoya J, Lei H, Moniatte M, Gruetter R. Sexual dimorphism in hepatic lipids is associated with the evolution of metabolic status in mice. NMR in Biomedicine 2017;30:e3761. [DOI: 10.1002/nbm.3761] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
85 Jäger S, Jacobs S, Kröger J, Stefan N, Fritsche A, Weikert C, Boeing H, Schulze MB. Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study. PLoS One. 2015;10:e0124749. [PMID: 25902304 DOI: 10.1371/journal.pone.0124749] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
86 Mazza A, Fruci B, Garinis GA, Giuliano S, Malaguarnera R, Belfiore A. The role of metformin in the management of NAFLD. Exp Diabetes Res. 2012;2012:716404. [PMID: 22194737 DOI: 10.1155/2012/716404] [Cited by in Crossref: 98] [Cited by in F6Publishing: 100] [Article Influence: 8.9] [Reference Citation Analysis]
87 Qi S, Wang C, Li C, Wang P, Liu M. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis. Medicine (Baltimore) 2017;96:e7743. [PMID: 28796060 DOI: 10.1097/MD.0000000000007743] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
88 Graf D, Weitkunat K, Dötsch A, Liebisch G, Döring M, Krüger R, Vatareck E, von Coburg E, Loh G, Watzl B. Specific Wheat Fractions Influence Hepatic Fat Metabolism in Diet-Induced Obese Mice. Nutrients 2019;11:E2348. [PMID: 31581733 DOI: 10.3390/nu11102348] [Reference Citation Analysis]
89 Oka R, Aizawa T, Yagi K, Hayashi K, Kawashiri M, Yamagishi M. Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men. Diabet Med 2014;31:552-8. [DOI: 10.1111/dme.12345] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
90 Bril F, Barb D, Lomonaco R, Lai J, Cusi K. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis. J Hepatol 2020;72:401-10. [PMID: 31589891 DOI: 10.1016/j.jhep.2019.09.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
91 Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations. World J Gastroenterol 2014; 20(28): 9330-9337 [PMID: 25071327 DOI: 10.3748/wjg.v20.i28.9330] [Cited by in F6Publishing: 123] [Reference Citation Analysis]
92 Teixeira TF, Alves RD, Moreira AP, Peluzio Mdo C. Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr Rev. 2015;73:175-190. [PMID: 26024540 DOI: 10.1093/nutrit/nuu007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
93 Soares AF, Lei H, Gruetter R. Characterization of hepatic fatty acids in mice with reduced liver fat by ultra-short echo time 1 H-MRS at 14.1 T in vivo: Hepatic Fatty Acid Compositon in Mice with Reduced Liver Fat. NMR Biomed 2015;28:1009-20. [DOI: 10.1002/nbm.3345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
94 Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu G, Königsrainer A, Machann J, Schick F, Hrabé de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Häring HU, Stefan N. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 2013;36:2331-8. [PMID: 23514731 DOI: 10.2337/dc12-1760] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
95 Comerford KB, Almario RU, Kim K, Karakas SE. Lean mass and insulin resistance in women with polycystic ovary syndrome. Metabolism 2012;61:1256-60. [PMID: 22424820 DOI: 10.1016/j.metabol.2012.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
96 Nakajima K, Oshida H, Muneyuki T, Saito M, Hori Y, Fuchigami H, Kakei M, Munakata H. Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study. BMJ Open 2013;3:e002235. [PMID: 23293250 DOI: 10.1136/bmjopen-2012-002235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
97 Berti L, Irmler M, Zdichavsky M, Meile T, Böhm A, Stefan N, Fritsche A, Beckers J, Königsrainer A, Häring HU, de Angelis MH, Staiger H. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol Metab 2015;4:519-27. [PMID: 26137439 DOI: 10.1016/j.molmet.2015.04.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
98 Robinson KN, Teran-garcia M. From infancy to aging: Biological and behavioral modifiers of Fetuin-A. Biochimie 2016;124:141-9. [DOI: 10.1016/j.biochi.2015.12.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
99 Murdolo G, Tortoioli C, Celi F, Bini V, Papi F, Brozzetti A, Falorni A. Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren. Endocrine 2017;56:357-65. [PMID: 27388590 DOI: 10.1007/s12020-016-1009-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
100 Stefan N, Häring H. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013;9:144-52. [DOI: 10.1038/nrendo.2012.258] [Cited by in Crossref: 292] [Cited by in F6Publishing: 268] [Article Influence: 32.4] [Reference Citation Analysis]
101 Pourhassan M, Glüer CC, Pick P, Tigges W, Müller MJ. Impact of weight loss-associated changes in detailed body composition as assessed by whole-body MRI on plasma insulin levels and homeostatis model assessment index. Eur J Clin Nutr 2017;71:212-8. [PMID: 27759067 DOI: 10.1038/ejcn.2016.189] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
102 Fehlert E, Wagner R, Ketterer C, Böhm A, Machann J, Fritsche L, Machicao F, Schick F, Staiger H, Stefan N, Häring H, Fritsche A, Heni M. Genetic determination of body fat distribution and the attributive influence on metabolism: Genetics of Fat Distribution Impact on Metabolism. Obesity 2017;25:1277-83. [DOI: 10.1002/oby.21874] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
103 Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A, Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD, Budoff MJ, Nasir K. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis. 2013;230:258-267. [PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052] [Cited by in Crossref: 190] [Cited by in F6Publishing: 188] [Article Influence: 21.1] [Reference Citation Analysis]
104 Williams AS, Kang L, Zheng J, Grueter C, Bracy DP, James FD, Pozzi A, Wasserman DH. Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance. J Biol Chem 2015;290:6546-57. [PMID: 25593319 DOI: 10.1074/jbc.M114.615716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
105 Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. Liver Transpl. 2019;25:56-67. [PMID: 30609189 DOI: 10.1002/lt.25338] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
106 Radwan MM, Radwan BM, Nandipati KC, Hunter WJ, Agrawal DK. Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Expert Rev Clin Immunol. 2013;9:727-738. [PMID: 23971751 DOI: 10.1586/1744666x.2013.816484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
107 Wagner R, Machann J, Lehmann R, Rittig K, Schick F, Lenhart J, Artunc F, Linder K, Claussen CD, Schleicher E, Fritsche A, Häring HU, Weyrich P. Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia 2012;55:2054-8. [PMID: 22526613 DOI: 10.1007/s00125-012-2551-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]